Durkin v. Equine Clinics, Inc.

546 A.2d 665, 376 Pa. Super. 557, 1988 Pa. Super. LEXIS 2223
CourtSupreme Court of Pennsylvania
DecidedAugust 10, 1988
Docket3280
StatusPublished
Cited by27 cases

This text of 546 A.2d 665 (Durkin v. Equine Clinics, Inc.) is published on Counsel Stack Legal Research, covering Supreme Court of Pennsylvania primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
Durkin v. Equine Clinics, Inc., 546 A.2d 665, 376 Pa. Super. 557, 1988 Pa. Super. LEXIS 2223 (Pa. 1988).

Opinions

CIRILLO, President Judge:

This is an appeal from an order of the Court of Common Pleas of Delaware County denying a motion to remove a compulsory nonsuit against appellants Edward Durkin, James Durkin, and Herve Filion [referred to collectively as “the Durkins”], who filed suit individually and as Snow Shoe Farms. In so doing, appellants in effect appeal the trial court’s decision to grant a motion in limine disallowing certain statements to be introduced as evidence at trial.

This appeal arises out of the death of appellants’ standardbred stallion, Josiah, who died, apparently of anaphylactic shock, after receiving a drug dose from appellee Joseph DeLeo, D.V.M. Josiah was stabled at Brandywine Racetrack under the care of Kenneth Seeber, D.V.M., a shareholder and employee of appellee Equine Clinics, Inc. Dr. Seeber had prescribed and was administering a regimen of drugs to the horse which included the enzyme, kymotripsin, brand-name Kymar. Because Dr. Seeber had to be away from the racetrack on August 21st, he left Josiah in [561]*561the care of Dr. DeLeo, asking him to carry out the regimen as prescribed. Dr. Seeber received a call at the airport from Dr. DeLeo, also an employee of Equine Clinics, who allegedly informed him that Josiah had died within ten minutes of his administering the drugs.

The Durkins brought suit for damages arising from the death of their horse. The matter went to trial on December 16, 1980. At trial, they argued that the horse’s death was caused by the drug Butazolidin which had been administered in twice the recommended dosage. Equine Clinics and Dr. DeLeo, appellees in the case, introduced evidence to show that Butazolidin could not produce an allergic reaction in a horse. The jury returned a verdict for appellees, and the trial judge entered judgment accordingly.

Appellants then appealed to this court. A panel of this court held that the trial court’s failure to instruct the jury that Dr. DeLeo’s administering Butazolidin in an amount in excess of the manufacturer’s recommended dosage was evidence from which the jury could infer that appellees had been negligent. The case was then remanded for a new trial. 313 Pa.Super. 75, 459 A.2d 417.

Before the second trial was to begin, appellees filed a motion in limine to bar admission of a statement made by Dr. Seeber to the Durkins the day following the death of their horse, indicating that the horse had died from a drug overdose, and a taped statement that Dr. Seeber had made to an insurance carrier investigator in February of 1972 while he was an employee and shareholder of Equine Clinics. That taped statement included Dr. Seeber’s acknowledgment that he had instructed Dr. DeLeo to administer the same drug regimen to Josiah that he had been administering, that the prescribed regimen included Kymar for lameness in the left hind leg, and that the enzyme could cause anaphylactic shock in a horse. He also said in his statement that Dr. DeLeo told him in the phone call that the horse had died of anaphylactic shock immediately after he had administered the drug regimen which had included Kymar. Dr. Seeber had testified to the contents of the taped statement [562]*562at the first trial, and the statement was introduced into evidence by appellees.

The motion in limine was granted after argument, and the matter proceeded to trial. The trial judge entered a compulsory nonsuit against appellants; their motion to remove the nonsuit was denied. They then appealed to this court.

The Durkins argue on appeal that the trial court erred in refusing to remove the compulsory nonsuit because Dr. Seeber’s statements were admissible and therefore appellants had presented sufficient evidence to go to the jury. Appellants further argue that Dr. Seeber’s statements were admissible because they fall under the vicarious admission exception to the hearsay rule, the judicial admission exception to the hearsay rule, and the prior inconsistent statement exception recently articulated by our supreme court in Commonwealth v. Brady, 510 Pa. 123, 507 A.2d 66 (1986). They also contend that the trial court erred in refusing to admit the statements on the basis that those statements were ostensibly based on inadmissible hearsay — Dr. DeLeo’s supposed statements to Dr. Seeber that he did in fact administer Kymar to the horse.

On appeal from an order denying a motion to remove a compulsory nonsuit, we must consider the record to determine whether the trial court properly applied the well-established standard for entry of a compulsory nonsuit. A nonsuit can only be entered in clear cases, and the plaintiff must be given the benefit of all evidence in his favor along with all favorable inferences that may be drawn from it. Any conflict in the evidence must be resolved in his favor. If a jury, viewing the evidence in the light most favorable to the plaintiff, could not reasonably determine that all the elements of the cause of action have been established, then the nonsuit is proper. Kuriger v. Cramer, 345 Pa.Super. 595, 602, 498 A.2d 1331, 1334-35 (1985). In this case, we must determine whether the trial court erred in holding the evidence in question inadmissible. We will reverse the ruling of the trial court only for an abuse of discretion. Concorde Investments, Inc. v. Gallagher, 345 [563]*563Pa.Super. 49, 56, 497 A.2d 637, 641 (1985). Should we find that the evidence was improperly excluded, the order granting the nonsuit would have to be reversed.

The Durkins argue that under the recent supreme court decision of Commonwealth v. Brady, 510 Pa. 123, 507 A.2d 66 (1986), the insurance statement given by Dr. Seeber should be permitted into evidence. They argue that Dr. Seeber’s testimony at the first trial was contradictory to the statement that he had given to the insurance company some six months after Josiah’s death, and that if he is called as a witness at the second trial, his testimony will continue to be inconsistent.

In Brady, the supreme court jettisoned an entire area of evidentiary law, and attempted to follow commentators perhaps less well-experienced in trial advocacy than the justices of the appellate courts of this Commonwealth. The court held that where a declarant is a witness at a judicial proceeding and is available for cross-examination, that declarant’s out of court statements may be admitted as substantive evidence for the truth of the matters asserted in them. Brady, 510 Pa. at 131, 507 A.2d at 70. Brady is now the law of this Commonwealth, although it should be noted that not even the Federal Rules of Evidence have taken as liberal a stance; under the Federal Rules, the prior inconsistent statement must have been given under oath before it can be accepted as substantive evidence. See F.R.E. 801(d)(1)(A).

In any event, we find that Brady is not applicable in this case. We note that the holding of the supreme court reads “otherwise admissible prior inconsistent statements ...

Free access — add to your briefcase to read the full text and ask questions with AI

Related

State Farm Mutual v. Palmer, D.
Superior Court of Pennsylvania, 2021
222 South Manoa v. Lavin, G.
Superior Court of Pennsylvania, 2020
Wilmington Savings v. United States
Superior Court of Pennsylvania, 2019
Wells Fargo Bank v. Dixon, D.K.
Superior Court of Pennsylvania, 2018
Nationstar Mortgage, LLC v. Kratz, J.
Superior Court of Pennsylvania, 2018
Citizens Bank v. Pincus, M.
Superior Court of Pennsylvania, 2018
U.S. Bank N.A. v. Schwartz, S.
Superior Court of Pennsylvania, 2018
In Re: Estate of Caruso, P., Appeal of: Caruso, G.
176 A.3d 346 (Superior Court of Pennsylvania, 2017)
Bank of America, N.A. v. Gibson
102 A.3d 462 (Superior Court of Pennsylvania, 2014)
Bank of America v. Gibson, M
Superior Court of Pennsylvania, 2014
Antoniotti v. Eckels
840 A.2d 1013 (Superior Court of Pennsylvania, 2003)
Mongeluzzi v. Pansini
61 Pa. D. & C.4th 52 (Philadelphia County Court of Common Pleas, 2001)
B & L Asphalt Industries, Inc. v. Fusco
753 A.2d 264 (Superior Court of Pennsylvania, 2000)
Brasure v. Optimum Choice Insurance
37 F. Supp. 2d 340 (D. Delaware, 1999)
Gibbs v. Herman
714 A.2d 432 (Superior Court of Pennsylvania, 1998)
National Union Fire Insurance v. Irex Corp.
713 A.2d 1145 (Superior Court of Pennsylvania, 1998)
Duquesne Light Co. v. Woodland Hills School District
700 A.2d 1038 (Commonwealth Court of Pennsylvania, 1997)
Sherman v. Franklin Regional Medical Center
660 A.2d 1370 (Superior Court of Pennsylvania, 1995)
Havasy v. Resnick
609 A.2d 1326 (Superior Court of Pennsylvania, 1992)

Cite This Page — Counsel Stack

Bluebook (online)
546 A.2d 665, 376 Pa. Super. 557, 1988 Pa. Super. LEXIS 2223, Counsel Stack Legal Research, https://law.counselstack.com/opinion/durkin-v-equine-clinics-inc-pa-1988.